Insider Trading activities of Urogen Pharma Ltd. (URGN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Urogen Pharma Ltd. (URGN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Urogen Pharma Ltd. since year 2005. Table 2 shows the detailed insider transactions of Urogen Pharma Ltd. since 2005. The reporting company's ticker symbol is URGN. The reporting company's CIK number is 1668243.
The total value of stock buying since 2005 is $525,527.
The total value of stock sales since 2005 is $8,803,381.
The total value of stock option exercises since 2005 is $769,408.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Urogen Pharma Ltd. (URGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-12 0 $0 0 $0 1,042 $0
2019-11 18,508 $515,461 962 $25,863 2,801 $0
2019-09 0 $0 343 $11,634 1,041 $0
2019-08 0 $0 2,024 $66,070 5,926 $0
2019-06 0 $0 0 $0 1,042 $0
2019-05 0 $0 608 $23,091 1,759 $0
2019-03 272 $10,066 1,991 $74,264 129,042 $514,559
2019-02 0 $0 2,804 $104,589 22,034 $254,849
2017-11 0 $0 209,298 $8,497,870 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Urogen Pharma Ltd. insiders (URGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-12-04 Schoenberg Mark (Chief Medical Officer) Option Ex 1,042 .00 0
2019-11-21 Barrett Elizabeth A. (Chief Executive Officer) Buy 7,530 28.00 210,840
2019-11-20 Barrett Elizabeth A. (Chief Executive Officer) Buy 7,470 28.00 209,160
2019-11-20 Pfreundschuh Peter P. (Chief Financial Officer) Sale 354 28.41 10,057
2019-11-20 Pfreundschuh Peter P. (Chief Financial Officer) Option Ex 1,042 .00 0
2019-11-19 Schoenberg Mark (Chief Medical Officer) Buy 1,960 28.17 55,213
2019-11-15 Barrett Elizabeth A. (Chief Executive Officer) Buy 1,548 26.00 40,248
2019-11-14 Mullennix Stephen (Chief Operating Officer) Sale 608 26.00 15,806
2019-11-14 Mullennix Stephen (Chief Operating Officer) Option Ex 1,759 .00 0
2019-09-04 Schoenberg Mark (Chief Medical Officer) Sale 343 33.92 11,634
2019-09-04 Schoenberg Mark (Chief Medical Officer) Option Ex 1,041 .00 0
2019-08-20 Pfreundschuh Peter P. (Chief Financial Officer) Sale 1,416 33.07 46,827
2019-08-20 Pfreundschuh Peter P. (Chief Financial Officer) Option Ex 4,167 .00 0
2019-08-15 Mullennix Stephen (Chief Operating Officer) Sale 608 31.65 19,243
2019-08-14 Mullennix Stephen (Chief Operating Officer) Option Ex 1,759 .00 0
2019-06-04 Schoenberg Mark (Chief Medical Officer) Option Ex 1,042 .00 0
2019-05-14 Mullennix Stephen (Chief Operating Officer) Sale 608 37.98 23,091
2019-05-14 Mullennix Stephen (Chief Operating Officer) Option Ex 1,759 .00 0
2019-03-27 Belldegrun Arie (Director) Option Ex 128,000 4.02 514,559
2019-03-21 Schoenberg Mark (Chief Medical Officer) Buy 272 37.01 10,066
2019-03-06 Schoenberg Mark (Chief Medical Officer) Sale 1,991 37.30 74,264
2019-03-04 Schoenberg Mark (Chief Medical Officer) Option Ex 1,042 .00 0
2019-02-14 Mullennix Stephen (Chief Operating Officer) Sale 2,804 37.30 104,589
2019-02-14 Mullennix Stephen (Chief Operating Officer) Option Ex 7,034 .00 0
2019-02-06 Cohen Fred E (Director) Option Ex 15,000 16.99 254,849
2017-11-28 Schreiber Alain (10% Owner) Sale 177,807 40.51 7,202,961
2017-11-27 Schreiber Alain (10% Owner) Sale 31,491 41.12 1,294,909

Insider trading activities including stock purchases, stock sales, and option exercises of URGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Urogen Pharma Ltd. (symbol URGN, CIK number 1668243) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month